Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Infectious Wound Care Management Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 117 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 117 pages
- Published: 07-06-2019
Market Overview
The growth of the market studied can be attributed to the increasing global geriatric population. As the population is increasing, age-related diseases are on the rise, thereby bolstering the demand for wound care management products. The current market is also growing due to the increasing prevalence of diabetes and rise in number of the accidents and burns. These factors are fueling the growth of the market studied. Due to the product innovations in the recent years, the market studied has been growing profitably worldwide.
Scope of the Report
The global infectious wound care management market (henceforth referred to as the market studied) involves the various products that help in healing and preventing infections. Wound care and closure and advanced wound care and closure products are used to treat acute and chronic wounds. Wound therapies have steadily advanced, to treat the patients more effectively and comprehensively. Over the next few years, the demand for wound care products is expected to increase significantly, particularly in the emerging economies.
Key Market Trends
Diabetes Mellitus Segment is Expected to exhibit Fastest Growth Rate Over the Forecast Period
Diabetic wounds are of three types: neuropathic, ischemic, and neuroischemic. Knowing the distinct features of each wound category is essential for identifying wound progression, infection, and healing. Failure in properly identifying the type of wound can lead to an ineffective diabetic wound treatment plan, causing long-term complications or amputation.
Infections are the main concern in any diabetic wound treatment plan. Due to the high morbidity and mortality rates associated with diabetic wounds, more aggressive forms of infection control are necessary. Both oral and topical antibiotics are recommended for all diabetic wound treatment patients who indicate signs of infection. A diabetes wound patient must be treated holistically, to reduce the risk factors that cause wounds. Achieving control over diabetes is difficult but essential, especially in terms of blood glucose levels, proper nutrition, high blood pressure, and smoking cessation.
North America captured the Largest Market Share and is expected to retain its Dominance
North America dominated the overall Infectious wound care management market, with the United States accounting for the major contribution to the same. The US segment of the market studied is the most progressive and lucrative in the world, with unconventional practices, products, and world-class clinicians.
According to the National Institutes of Health, human skin wound is a significant indirect threat to the US economy, as the government takes responsibility for the treatment of the public. This has prompted the government to invest significant amounts of money toward developing effective treatment methods. Research in the United States has revealed that the incidence of non-healing cutaneous wounds is about USD 5-7 million per year, in the country. The relative expenditure for these wounds is about USD 25 billion.
Competitive Landscape
Competition among the existing players is high and price pressure has been increasing among the vendors. Despite the high number of market participants, the majority of the market share is controlled by a handful of participants. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Bristol-Myers Squibb Company, Cardinal Health Inc., Sanofi, Smith & Nephew, and 3M, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Diabetes
4.2.2 Rising Aging Population
4.2.3 Increasing Number of Accidents and Burn Cases
4.3 Market Restraints
4.3.1 Risks Associated with Improper Usage and Application of Wound Care Products
4.3.2 Side Effects of Antibiotics
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Therapy
5.1.1.1 Antibiotic Therapy
5.1.1.2 Iodine Therapy
5.1.1.3 Silver Therapy
5.1.1.4 Other Therapies
5.1.2 Device
5.1.2.1 Wound Dressing
5.1.2.1.1 Film Dressing
5.1.2.1.2 Silver Dressing
5.1.2.1.3 Alginate Dressing
5.1.2.1.4 Other Devices
5.1.2.2 Compression Bandage
5.1.2.3 Negative Pressure Wound Therapy
5.2 Type of Wound
5.2.1 Diabetes Mellitus
5.2.2 Autoimmune Disorder
5.2.3 Hypoxia/Poor Tissue Perfusion
5.2.4 Other Types of Wound
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bristol-Myers Squibb Company
6.1.2 Cardinal Health Inc.
6.1.3 Sanofi
6.1.4 Smith & Nephew
6.1.5 Molnlycke Health Care AB
6.1.6 3M
6.1.7 Kinetics Concept Company
6.1.8 Coloplast Group
6.1.9 Convatec Group PLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Therapy
Antibiotic Therapy
Iodine Therapy
Silver Therapy
Other Therapies
Device
Wound Dressing
Film Dressing
Silver Dressing
Alginate Dressing
Other Devices
Compression Bandage
Negative Pressure Wound Therapy
Type of Wound
Diabetes Mellitus
Autoimmune Disorder
Hypoxia/Poor Tissue Perfusion
Other Types of Wound
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Influenza Diagnostics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global influenza diagnostics market was valued at USD 492.42 million in 2018, and is estimated to be valued at USD 731.97 million in 2024, witnessing a CAGR of 6.83%. Certain factors that are driving the market growth include increasing prevalence of influenza and related chronic diseases, growth in research funding for influenza diagnostics, and rising demand for early diagnosis and control of influenza.
Influenza is recognized as a crucial cause of morbidity and mortality in the human population, which is leading to the development and use of diagnostics that are intended for reducing consequent health and economic impacts. According to WHO, in 2018, influenza caused severe sickness or death mainly in patients at a high risk and illness range from mild to severe and even death. Also, this annual increase is projected to result in about 3-5 million cases of severe illness, and about 290,000-650,000 deaths, globally.
Various initiatives and research funding are bolstering the growth of the market. For instance, National Institute of Allergy and Infectious Disease (NIAID) has supported a broad portfolio of the influenza research, which includes studies that are informing the development of vaccines, diagnostics, and therapeutics against seasonal and pandemic influenza. Similarly, in 2018, a non-profit association between academic, government, and industry medical researchers, called Human Vaccine Project, launched the Universal Influenza Vaccine Initiative. Thus, growth in research funding by the government and companies for influenza diagnostics is driving the market.
However, it is critical to ensure that all the rapid antigen flu tests meet new FDA requirements for approval. Hence, the stringent FDA regulations act as significant restraints for the market.
Scope of the Report
Influenza, also known as flu, is a highly contagious infectious disease caused by a virus. This is an infection of the respiratory passages, which causes fever and severe aches. The influenza diagnostic market includes the tests that are conducted for the diagnosis of influenza cases. As per the scope of this report, only the test kits and reagents that are being used for the diagnosis of influenza have been taken into account for the calculation of the total market size.
Key Market Trends
Rapid Influenza Diagnostic Test (RIDT) is Expected to hold its Highest Market Share in the Test Type Segment
In the test type segment of the influenza diagnostics market, among all traditional diagnostic tests, the rapid influenza diagnostic test (RIDT) is believed to have the largest market size and is expected to witness a CAGR of 6.87% during the forecast period.
Rapid influenza diagnostic tests (RIDTs) are immunoassays, which help to identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and qualitatively provide the results. It can diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms.
The rising popularity of RIDT is due to the benefits of faster result and simple usage. Some of the RIDTs are also approved for office/bedside use as well. The RIDT segment is also expected to witness rapid growth, as a result of their common usage in point-of-care settings.
However, one of the major drawback associated with RIDT is that it gives false negative results, due to its low to moderate sensitivities (50-70%). Healthcare policymakers began to recognize the impact of its low sensitivity in 2009, when the novel H1N1 influenza epidemic occurred.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for influenza diagnostics and is expected to continue its stronghold for a few more years.
As per data published by the Centers for Disease Control and Prevention (CDC), RIDTs are commonly available across the region. The reason behind the wide availability of the test is the reduced time span needed to generate results. RIDT can yield results in 15 minutes. With increasing influenza-associated hospitalization and pediatric deaths and the interest of government organizations to better manage the disease, the North American influenza diagnostics market is expected to grow in the future.
Competitive Landscape
The influenza diagnostics market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche AG, Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, and Sekisui Diagnostics., among others, hold the substantial share in the market.
Various developments have recently been taking place in the market; for instance, in March 2018, Sekisui Diagnostics launched the Silaris Influenza A and B test, developed in collaboration with Mesa Biotech. Also, in October 2017, Abbott Laboratories acquired Alere Inc. (Alere), a diagnostic device and service provider, which strengthened the company’s diagnostics presence.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Influenza and Related Chronic Diseases
4.2.2 Growth in Research Funding for Influenza Diagnostics
4.2.3 Rising Demand for Early Diagnosis and Control of Influenza
4.3 Market Restraints
4.3.1 Product Safety and High Cost of Development
4.3.2 Stringent Government Regulations
4.3.3 Variability in Sensitivity and Specificity among Influenza Diagnostic Tests
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Test Type
5.1.1 Traditional Diagnostic Test
5.1.1.1 Rapid Influenza Diagnostic Test (RIDT)
5.1.1.2 Viral Culture
5.1.1.3 Direct Fluorescent Antibody (DFA) Test
5.1.1.4 Serological Assay
5.1.2 Molecular Diagnostic Assay
5.1.2.1 RT-PCR
5.1.2.2 Nucleic Acid Sequence-based Amplification (NASBA) Test
5.1.2.3 Loop-mediated Isothermal Amplification-based Assay (LAMP)
5.1.2.4 Simple Amplification-based Assay (SAMBA)
5.1.2.5 Other Molecular Diagnostic Assays
5.2 End User
5.2.1 Hospital
5.2.2 Research Laboratory
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Becton, Dickinson and Company
6.1.3 Coris BioConcept
6.1.4 DiaSorin SpA
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Luminex Corporation
6.1.7 Meridian Bioscience Inc.
6.1.8 Quidel Corporation
6.1.9 Sekisui Diagnostics
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Test Type
Traditional Diagnostic Test
Rapid Influenza Diagnostic Test (RIDT)
Viral Culture
Direct Fluorescent Antibody (DFA) Test
Serological Assay
Molecular Diagnostic Assay
RT-PCR
Nucleic Acid Sequence-based Amplification (NASBA) Test
Loop-mediated Isothermal Amplification-based Assay (LAMP)
Simple Amplification-based Assay (SAMBA)
Other Molecular Diagnostic Assays
End User
Hospital
Research Laboratory
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Insulin Infusion Pumps Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 100 pages | Published: 13-06-2019 |
- Healthcare
- Mordor Intelligence
- 100 pages
- Published: 13-06-2019
Market Overview
The global insulin infusion pump market is set to witness a CAGR of 7.51% during the forecast period. Insulin infusion pumps work as an alternative to the traditional system of daily injections or an insulin pen.
Insulin infusion pumps reduce the large swings in blood glucose level, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps.
This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.
The insulin pump has evolved and is more reliable than it was previously. CSII technology has witnessed numerous technological advancements, like the integration of continuous glucose monitoring with the pump. Now, insulin pumps can control the algorithm that automatically delivers the insulin, after analyzing the blood glucose reading
Scope of the Report
The insulin market is segmented into the device, infusion set, and reservoir. The report is also segmented into five regions: North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America.
Key Market Trends
The Insulin Pump Market is Growing with the CAGR of 7% in the Forecast Period
Owing to the rising rate of obesity, growing genetic factors for type 2 diabetes, and the increasing number of type 1 diabetes patients, it is likely that the insulin infusion pump market will continue to grow.
Insulin pump use is high among the type 1 population. It is also growing in type 2 patients. The ratio of children to adult, or type 1 to type 2, patient’s usage of insulin pumps varies across countries.
North America Holds the Highest Market Share
North America holds the highest market share in the insulin pump market and is also expected to grow with the highest CAGR, of 9.05% in the forecast period, because of the favorable reimbursement policy. Although the pump and its supplies (tubing, insulin cartridges, and infusion sets) continue to be expensive, insurance coverage has improved considerably over the years.
Competitive Landscape
Animas had to exit the insulin pump market, as the company has admitted that rising competition was the reason for them to leave the market.
Medtronic is the market leader and is expected to maintain its position during the forecast period.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product (Value and Volume 2012-2024)
5.1.1 Insulin Pumps
5.1.2 Infusion Sets
5.1.3 Reservoirs
5.2 Geography
5.2.1 North America
5.2.1.1 United States (Value and Volume 2012-2024)
5.2.1.1.1 By Insulin Pump Devices
5.2.1.1.2 By Infusion Sets
5.2.1.1.3 By Reservoirs
5.2.1.2 Canada (Value and Volume 2012-2024)
5.2.1.2.1 By Insulin Pump Devices
5.2.1.2.2 By Infusion Sets
5.2.1.2.3 By Reservoirs
5.2.1.3 Rest of North America (Value and Volume 2012-2024)
5.2.1.3.1 By Insulin Pump Devices
5.2.1.3.2 By Infusion Sets
5.2.1.3.3 By Reservoirs
5.2.2 Asia-Pacific
5.2.2.1 Japan (Value and Volume 2012-2024)
5.2.2.1.1 By Insulin Pump Devices
5.2.2.1.2 By Infusion Sets
5.2.2.1.3 By Reservoirs
5.2.2.2 South Korea (Value and Volume 2012-2024)
5.2.2.2.1 By Insulin Pump Devices
5.2.2.2.2 By Infusion Sets
5.2.2.2.3 By Reservoirs
5.2.2.3 China (Value and Volume 2012-2024)
5.2.2.3.1 By Insulin Pump Devices
5.2.2.3.2 By Infusion Sets
5.2.2.3.3 By Reservoirs
5.2.2.4 India (Value and Volume 2012-2024)
5.2.2.4.1 By Insulin Pump Devices
5.2.2.4.2 By Infusion Sets
5.2.2.4.3 By Reservoirs
5.2.2.5 Australia (Value and Volume 2012-2024)
5.2.2.5.1 By Insulin Pump Devices
5.2.2.5.2 By Infusion Sets
5.2.2.5.3 By Reservoirs
5.2.2.6 Vietnam (Value and Volume 2012-2024)
5.2.2.6.1 By Insulin Pump Devices
5.2.2.6.2 By Infusion Sets
5.2.2.6.3 By Reservoirs
5.2.2.7 Malaysia (Value and Volume 2012-2024)
5.2.2.7.1 By Insulin Pump Devices
5.2.2.7.2 By Infusion Sets
5.2.2.7.3 By Reservoirs
5.2.2.8 Indonesia (Value and Volume 2012-2024)
5.2.2.8.1 By Insulin Pump Devices
5.2.2.8.2 By Infusion Sets
5.2.2.8.3 By Reservoirs
5.2.2.9 Philippines (Value and Volume 2012-2024)
5.2.2.9.1 By Insulin Pump Devices
5.2.2.9.2 By Infusion Sets
5.2.2.9.3 By Reservoirs
5.2.2.10 Thailand (Value and Volume 2012-2024)
5.2.2.10.1 By Insulin Pump Devices
5.2.2.10.2 By Infusion Sets
5.2.2.10.3 By Reservoirs
5.2.2.11 Rest of Asia-Pacific (Value and Volume 2012-2024)
5.2.2.11.1 By Insulin Pump Devices
5.2.2.11.2 By Infusion Sets
5.2.2.11.3 By Reservoirs
5.2.3 Europe
5.2.3.1 United Kingdom (Value and Volume 2012-2024)
5.2.3.1.1 By Insulin Pump Devices
5.2.3.1.2 By Infusion Sets
5.2.3.1.3 By Reservoirs
5.2.3.2 France (Value and Volume 2012-2024)
5.2.3.2.1 By Insulin Pump Devices
5.2.3.2.2 By Infusion Sets
5.2.3.2.3 By Reservoirs
5.2.3.3 Germany (Value and Volume 2012-2024)
5.2.3.3.1 By Insulin Pump Devices
5.2.3.3.2 By Infusion Sets
5.2.3.3.3 By Reservoirs
5.2.3.4 Italy (Value and Volume 2012-2024)
5.2.3.4.1 By Insulin Pump Devices
5.2.3.4.2 By Infusion Sets
5.2.3.4.3 By Reservoirs
5.2.3.5 Spain (Value and Volume 2012-2024)
5.2.3.5.1 By Insulin Pump Devices
5.2.3.5.2 By Infusion Sets
5.2.3.5.3 By Reservoirs
5.2.3.6 Russia (Value and Volume 2012-2024)
5.2.3.6.1 By Insulin Pump Devices
5.2.3.6.2 By Infusion Sets
5.2.3.6.3 By Reservoirs
5.2.3.7 Rest of Europe (Value and Volume 2012-2024)
5.2.3.7.1 By Insulin Pump Devices
5.2.3.7.2 By Infusion Sets
5.2.3.7.3 By Reservoirs
5.2.4 Latin America
5.2.4.1 Mexico (Value and Volume 2012-2024)
5.2.4.1.1 By Insulin Pump Devices
5.2.4.1.2 By Infusion Sets
5.2.4.1.3 By Reservoirs
5.2.4.2 Brazil (Value and Volume 2012-2024)
5.2.4.2.1 By Insulin Pump Devices
5.2.4.2.2 By Infusion Sets
5.2.4.2.3 By Reservoirs
5.2.4.3 Rest of Latin America (Value and Volume 2012-2024)
5.2.4.3.1 By Insulin Pump Devices
5.2.4.3.2 By Infusion Sets
5.2.4.3.3 By Reservoirs
5.2.5 Middle East & Africa
5.2.5.1 Saudi Arabia (Value and Volume 2012-2024)
5.2.5.1.1 By Insulin Pump Devices
5.2.5.1.2 By Infusion Sets
5.2.5.1.3 By Reservoirs
5.2.5.2 Iran (Value and Volume 2012-2024)
5.2.5.2.1 By Insulin Pump Devices
5.2.5.2.2 By Infusion Sets
5.2.5.2.3 By Reservoirs
5.2.5.3 Egypt (Value and Volume 2012-2024)
5.2.5.3.1 By Insulin Pump Devices
5.2.5.3.2 By Infusion Sets
5.2.5.3.3 By Reservoirs
5.2.5.4 Oman (Value and Volume 2012-2024)
5.2.5.4.1 By Insulin Pump Devices
5.2.5.4.2 By Infusion Sets
5.2.5.4.3 By Reservoirs
5.2.5.5 South Africa (Value and Volume 2012-2024)
5.2.5.5.1 By Insulin Pump Devices
5.2.5.5.2 By Infusion Sets
5.2.5.5.3 By Reservoirs
5.2.5.6 Rest of Middle East & Africa (Value and Volume 2012-2024)
5.2.5.6.1 By Insulin Pump Devices
5.2.5.6.2 By Infusion Sets
5.2.5.6.3 By Reservoirs
6 MARKET INDICATORS
6.1 Type-1 Diabetes Population (2012-2024)
6.2 Type-2 Diabetes Population (2012-2024)
7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Medtronic
7.1.2 Insulet
7.1.3 Roche
7.1.4 Animas
7.1.5 Tandem
7.1.6 Ypsomed
7.1.7 Cellnovo
7.2 COMPANY SHARE ANALYSIS
7.2.1 Roche
7.2.2 Animas
7.2.3 Medtronic
7.2.4 Others
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product (Value and Volume 2012-2024)
Insulin Pumps
Infusion Sets
Reservoirs
Geography
North America
United States (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Canada (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of North America (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Asia-Pacific
Japan (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Korea (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
China (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
India (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Australia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Vietnam (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Malaysia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Indonesia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Philippines (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Thailand (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Asia-Pacific (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Europe
United Kingdom (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
France (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Germany (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Italy (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Spain (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Russia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Europe (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Latin America
Mexico (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Brazil (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Latin America (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Middle East & Africa
Saudi Arabia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Iran (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Egypt (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Oman (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Africa (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Middle East & Africa (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Ion Chromatography Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global ion chromatography market is due to the increasing use of ion-exchange chromatography for purification, along with the increasing demand for monoclonal antibodies, which is a primary driver for the market. The current market is also growing due to the increasing adoption of ion-exchange techniques in the food, beverage, and water industries. To check content, quality, or safety, ion chromatography is increasingly being used in various industries. The ion-exchange technique is also being used to check the presence or amount of ingredients in a sample. The high cost of chromatography instruments and the lack of skilled personnel to handle the equipment are hindering the growth of the ion chromatography market.
Scope of the Report
This report estimates the global ion chromatography market. It incorporates a detailed analysis of technology, which includes ion-exchange chromatography, ion-exclusion chromatography, and ion-pair chromatography. Ion chromatography is a well-established technique for the analysis of anions and cations in liquid, gaseous, and solid samples. Organizations, such as the ISO, US EPA, ASTM, and AOAC have established their standards on regulatory methods of analysis using this technique. Currently, electrochemical and spectrometric methods are the two detection methods applied in ion chromatography.
Key Market Trends
Ion-exchange Chromatography Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
There are two types of ion-exchange chromatography techniques, based on the nature of charge present on the ion. They are anion exchange chromatography and cation exchange chromatography. Ion exchange resins are useful as carriers for medicinal materials and in slow release applications. Cholestyramine, a dried and ground strong base anion resin, is used in binding the bile acid for reducing blood cholesterol. The usage of this ion exchange in the medical field is increasing, and thus, driving the market growth.
One of the main advantages of ion exchange is that there is only one interaction involved in the separation, the analytical species interacting with the stationary phase; while the downside of ion-exchange chromatography is the high cost of these columns. The ion-exchange chromatography market share is dominant, due to a wide range of applications and associated markets. This market share is expected to increase further during the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
In the United States, ion chromatography is used for many applications. Ion chromatography (IC) has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, food testing, and other applications. The United States Pharmacopeia (USP) is a non-government not-for-profit organization that supports itself through the sale of books (USP-NF and other publications) and reference standards. USP sets standards for the use of ion chromatography in pharmaceutical applications. Many organizations, such as USEPA (United States Environmental Protection Agency), ASTM (American Society for Testing and Materials), and AOAC (Association of Official Analytical Chemists) are some of the additions to the market in the United States. These organizations also develop standards or regulatory methods of analysis for various applications of ion chromatography.
Competitive Landscape
Agilent Technologies, Bio-Rad Laboratories Inc., GE Healthcare, Metrohm AG, and Mitsubishi Chemical Corporation are some of the major players in the ion chromatography market that are disrupting the market by launching several new products.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Academic and Commercial R&D Spending on Pharmaceuticals
4.2.2 Increasing Use of Ion Chromatography Technique in Purifying Monoclonal Antibodies (MABS)
4.2.3 Increasing Use of Ion Chromatography Technique in the Food, Beverage, and Water Industries
4.2.4 Technological Advancements in Ion Chromatography
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.3.2 Lack of Skilled Personnel to Handle Equipment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Technology
5.1.1 Ion-exchange Chromatography
5.1.2 Ion-exclusion Chromatography
5.1.3 Ion-pair Chromatography
5.2 Application
5.2.1 Environmental Testing
5.2.2 Pharmaceutical Industry
5.2.3 Food Industry
5.2.4 Chemicals Industry
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 GE Healthcare
6.1.4 Metrohm AG
6.1.5 Mitsubishi Chemical Corporation
6.1.6 Perkin Elmer Inc.
6.1.7 Shimadzu Corporation
6.1.8 Thermo Fisher Scientific
6.1.9 Tosoh Corporation
6.1.10 Waters
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Technology
Ion-exchange Chromatography
Ion-exclusion Chromatography
Ion-pair Chromatography
Application
Environmental Testing
Pharmaceutical Industry
Food Industry
Chemicals Industry
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Iron Deficiency Anemia Therapy Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
Iron deficiency anemia is a common condition affecting, especially, children and young women across the world. Iron deficiency is a major problem in developed countries, such as the United States, Canada, the United Kingdom, and across Europe. Moreover, in developing countries, iron deficiency anemia is frequently exacerbated by malaria and other worm infections. The current market is growing, due to the rising incidences of iron deficiency anemia. The increasing risk of hemodilution in pregnant women acts as a major driver for this market. The need to reduce the burden of iron-deficiency anemia has led to an increase in the demand for its treatment, which subsequently drives the global market.
Scope of the Report
This report estimates the global iron deficiency anemia therapy market. It includes a detailed analysis of the various available therapies for treating anemia in healthcare facilities of major geographical regions. Iron deficiency anemia is caused due to the lack of iron and is is one of the most common types of anemia. In case of women, during the child-bearing age, iron loss in the blood will be caused due to heavy menstruation or pregnancy. Certain intestinal diseases and poor diet can also cause anemia.
Key Market Trends
Parenteral Iron Therapy Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Parenteral iron therapy is generally offered to patients who are either unable to absorb oral iron or are still diagnosed with increasing anemia, even after taking adequate doses of oral iron supplements. Many intravenous iron supplementation products are being approved by FDA, which is likely to drive the market in the future. Administration of parenteral iron supplement can lead to adverse effects, such as anaphylaxis, shock, severe hypotension, collapse, and loss of consciousness. Prevalence of anemia cases and patients’ irresponsiveness toward oral and dietary therapies are the factors likely to drive the market over the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall iron deficiency anemia therapy market, with the United States being the major contributor to the market. The prevalence of anemia is a significant public health indicator and has remained a relevant health concern in the United States. Since 1990, the prevalence rate of iron deficiency anemia in US infants did not drop, making iron deficiency a significant public health problem in the United States. Hence, the high prevalence rate of anemia is expected to boost the growth of the market in North America.
Competitive Landscape
High sustainable competitive advantage through innovation is also contributing to the increasing competitive rivalry. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Allergan, Integra Lifesciences, Galderma Pharma SA, Teoxane, and Sinclair Pharma PLC, among others. The industry is witnessing a series of acquisitions and mergers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cases of Haemodilution in Pregnancy
4.2.2 High Prevalence of Anemia
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines
4.3.2 Adverse Effects
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Therapy Type
5.1.1 Oral Iron Therapy
5.1.2 Parenteral Iron Therapy
5.1.3 Red Blood Cell Transfusion
5.1.4 Other Therapy Types
5.2 End User
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Home Healthcare
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergen
6.1.2 Akebia Therapeutics
6.1.3 AMAG Pharmaceuticals
6.1.4 Keryx Biopharmaceuticals Inc.
6.1.5 Luitpold Pharmaceuticals Inc.
6.1.6 Johnson & Johnson
6.1.7 Pharmacosmos AS
6.1.8 Pieris
6.1.9 Allergen
6.1.10 AMAG Pharmaceuticals
6.1.11 Johnson & Johnson
6.1.12 Pharmacosmos A/S
6.1.13 Pieris
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Therapy Type
Oral Iron Therapy
Parenteral Iron Therapy
Red Blood Cell Transfusion
Other Therapy Types
End User
Hospitals
Clinics
Home Healthcare
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Laboratory Informatics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 116 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 07-06-2019
Market Overview
The global laboratory informatics market was valued at USD 2,395.69 million in 2018, and is estimated to be valued at USD 3,729.23 million in 2024, witnessing a CAGR of 7.65%. Factors that are driving the market include high accuracy and efficiency of results, increasing applications of lab informatics solutions, and increasing number of diagnoses.
Owing to the increased workload, cost constraints, and advancements in technologies, the nature of pathology is rapidly changing, as per the need of the market. New laboratory systems are manufactured with the best technologies to alleviate the current global demand. New approaches for managing laboratory information are now required to fulfill the changing requirements of the healthcare system. The primary concern for clinicians is the accuracy of the information that they get through various resources. However, it was stated by the World Health Organization that around 5% of the patients face diagnostic errors each year in the developed countries, and about 7% of the abnormal test results are not delivered to the patients. Thus, to avoid these diagnostic errors and to provide better services, clinics and laboratories are implementing various tools, such as laboratory information systems (LIS) and LIMS.
Scope of the Report
Laboratory informatics is the specialized application of information with the help of a platform consisting of equipment, software, and data management tools that allow scientific data to be captured, migrated, processed, and interpreted for immediate use, as well as for future use.
Key Market Trends
Laboratory Information Management System is Expected to hold its Highest Market Share in the Product
In the product segment of the laboratory informatics market, laboratory information management system is believed to have the largest market size and is expected to witness a CAGR of 7.18% during the forecast period.
LIMS are usually intended for the laboratories having recurring workflows, such as quality control laboratories. LIM system contains a special data structure, and the processes of the laboratory (workflow) should already be established in a certain format. LIMS products have been losing market share to electronic lab notebooks (ELN) and laboratory execution system (LES) in the recent years. This trend can be observed in the sales growth of LES vendors and in the investment of large LIMS providers in the field of ELN and LES. Some of the major players in the market studied, such as LabVantage Solutions Inc., have invested heavily, in order to develop comprehensive and highly integrated LES and ELN capabilities.
North America Domainates the Market and is Expected to do the Same in the Forecasted Period
North America currently dominates the market for laboratory informatics and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the well-established healthcare industry and better reimbursement facilities in the region. The United States holds the majority of the market in the North American region, due to the higher adoption of digital healthcare in the country and the rising investments done by the companies over there.
Competitive Landscape
The laboratory informatics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. Companies, like Abbott Laboratories (Abbott Informatics Corporation), Agilent Technologies, McKesson Corporation, Thermo Fischer Scientific Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Accuracy and Efficiency of Results
4.2.2 Increasing Applications of Lab Informatics Solutions
4.2.3 Increasing Number of Diagnoses
4.3 Market Restraints
4.3.1 Lack of Integration Standards for Laboratory Informatics
4.3.2 Lack of Skilled Professionals
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Laboratory Information Management System (LIMS)
5.1.2 Electronic Lab Notebooks (ELN)
5.1.3 Enterprise Content Management (ECM)
5.1.4 Laboratory Execution System (LES)
5.1.5 Chromatography Data System (CDS)
5.1.6 Scientific Data Management System (SDMS)
5.1.7 Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
5.2 By Component
5.2.1 Services
5.2.2 Software
5.3 By Delivery Mode
5.3.1 On-premise
5.3.2 Web-hosted
5.3.3 Cloud-based
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories (Abbott Informatics Corporation)
6.1.2 Agilent Technologies
6.1.3 Cerner Corporation
6.1.4 McKesson Corporation
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 LabLynx Inc.
6.1.7 LabVantage Solutions Inc.
6.1.8 LabWare Inc.
6.1.9 PerkinElmer Inc.
6.1.10 Waters Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Laboratory Information Management System (LIMS)
Electronic Lab Notebooks (ELN)
Enterprise Content Management (ECM)
Laboratory Execution System (LES)
Chromatography Data System (CDS)
Scientific Data Management System (SDMS)
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
By Component
Services
Software
By Delivery Mode
On-premise
Web-hosted
Cloud-based
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America